Engaging Broader Stakeholders to Accelerate Group A <i>Streptococcus</i> Vaccine Development
Group A <i>Streptococcus</i> (GAS) imposes a significant global health burden across all age groups, annually causing over 600 million cases of pharyngitis and more than 18 million severe invasive infections or sequelae. The resurgence of scarlet fever globally and streptococcal toxic sh...
Saved in:
| Main Authors: | Dechuan Kong, Hao Pan, Huanyu Wu, Jian Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/7/734 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
“Prevention of Group B <i>Streptococcus</i> by Vaccination,” Will It Transform Maternal and Neonatal Health?
by: Keyur D Mahajan
Published: (2023-09-01) -
Unraveling Pediatric Group A Streptococcus Meningitis: Lessons from Two Case Reports and a Systematic Review
by: Lavinia Di Meglio, et al.
Published: (2025-05-01) -
Molecular and Clinical Characterization of Invasive <i>Streptococcus pyogenes</i> Isolates: Insights from Two Northern-Italy Centers
by: Carmelo Bonomo, et al.
Published: (2025-02-01) -
<i>Streptococcus salivarius</i> Role as a Probiotic in Children’s Health and Disease Prophylaxis—A Systematic Review
by: Flavia Cristina Al-Akel, et al.
Published: (2024-12-01) -
Impact of the SARS-CoV-2 Pandemic on the Epidemiology of <i>Streptococcus pyogenes</i>: A Five-Year Retrospective Study
by: Patricia Brañas, et al.
Published: (2024-11-01)